ARTL
Artelo Biosciences IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$2.78M
P/E Ratio
—
EPS
$-29.01
Beta
0.05
52W High
$85.80
52W Low
$1.19
50-Day MA
$4.56
200-Day MA
$8.82
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Artelo Biosciences Inc
Artelo Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. The company is headquartered in La Jolla, California.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-7.44M |
| Operating Margin | 0.00% |
| Return on Equity | -367.70% |
| Return on Assets | -91.30% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $7.62 |
| Price-to-Book | 0.42 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | 1.22 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $2.33M |
| Float | $2.12M |
| % Insiders | 4.31% |
| % Institutions | 12.10% |
More HEALTHCARE Stocks
Data last updated: 5/25/2026